Inhibition of type 1 diabetes in filaria-infected non-obese diabetic mice is associated with a T helper type 2 shift and induction of FoxP3+ regulatory T cells

Immunology

Volumn 127, Issue 4, 2009, Pages 512-522

  Hübner, Marc P ^a   Thomas Stocker, J ^a   Mitre, Edward ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Autoimmune; Diabetes; Helminth; Immunomodulation; Litomosoides sigmodontis

Indexed keywords

ALPHA CD28 ANTIGEN; ALPHA CD3 ANTIGEN; IMMUNOGLOBULIN G1; INSULIN; INTERLEUKIN 4; INTERLEUKIN 5; LITOMOSOIDES SIGMODONTIS ANTIGEN; LYMPHOCYTE ANTIGEN; PARASITE ANTIGEN; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL COUNT; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; FILARIASIS; FLOW CYTOMETRY; HISTOPATHOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; LITOMOSOIDES SIGMODONTIS; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS ISLET CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SPLEEN CELL; TH2 CELL;

ANIMALS; ANTIGENS, HELMINTH; AUTOANTIBODIES; AUTOIMMUNITY; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; FEMALE; FILARIASIS; FILARIOIDEA; FORKHEAD TRANSCRIPTION FACTORS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INSULIN; MICE; MICE, INBRED BALB C; MICE, INBRED NOD; SPLEEN; T-LYMPHOCYTES, REGULATORY; TH2 CELLS;

EID: 67650487180     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2008.02958.x     Document Type: Article

References (34)

1. Tisch R, McDevitt H. Insulin-dependent diabetes mellitus. Cell 1996 85 : 291 7.
2. Kay TW, Chaplin HL, Parker JL, Stephens LA, Thomas HE. CD4+ and CD8+ T lymphocytes: clarification of their pathogenic roles in diabetes in the NOD mouse. Res Immunol 1997 148 : 320 7.
3. Katz JD, Benoist C, Mathis D. T helper cell subsets in insulin-dependent diabetes. Science 1995 268 : 1185 8.
4. Pugliatti M, Sotgiu S, Rosati G. The worldwide prevalence of multiple sclerosis. Clin Neurol Neurosurg 2002 104 : 182 91.
5. Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 2004 126 : 1504 17.
6. Gale EA. The rise of childhood type 1 diabetes in the 20th century. Diabetes 2002 51 : 3353 61.
7. Onkamo P, Vaananen S, Karvonen M, Tuomilehto J. Worldwide increase in incidence of type I diabetes - the analysis of the data on published incidence trends. Diabetologia 1999 42 : 1395 403.
8. Elliott DE, Summers RW, Weinstock JV. Helminths as governors of immune-mediated inflammation. Int J Parasitol 2007 37 : 457 64.
9. Zaccone P, Fehervari Z, Phillips JM, Dunne DW, Cooke A. Parasitic worms and inflammatory diseases. Parasite Immunol 2006 28 : 515 23.
10. Correale J, Farez M. Association between parasite infection and immune responses in multiple sclerosis. Ann Neurol 2007 61 : 97 108. (Pubitemid 46363837)
11. Fleming JO, Cook TD. Multiple sclerosis and the hygiene hypothesis. Neurology 2006 67 : 2085 6.
12. Cooke A, Tonks P, Jones FM, O'Shea H, Hutchings P, Fulford AJ, Dunne DW. Infection with Schistosoma mansoni prevents insulin dependent diabetes mellitus in non-obese diabetic mice. Parasite Immunol 1999 21 : 169 76.
13. Saunders KA, Raine T, Cooke A, Lawrence CE. Inhibition of autoimmune type 1 diabetes by gastrointestinal helminth infection. Infect Immun 2007 75 : 397 407. (Pubitemid 46047916)
14. El-Wakil HS, Aboushousha TS, El Haddad O, Gamil NB, Mansour T, El-Said H. Effect of Schistosoma mansoni egg deposition on multiple low doses streptozotocin induced insulin dependent diabetes. J Egypt Soc Parasitol 2002 32 : 987 1002.
15. La Flamme AC, Ruddenklau K, Backstrom BT. Schistosomiasis decreases central nervous system inflammation and alters the progression of experimental autoimmune encephalomyelitis. Infect Immun 2003 71 : 4996 5004. (Pubitemid 37070742)
16. Elliott DE, Li J, Blum A, Metwali A, Qadir K, Urban JF Jr., Weinstock JV. Exposure to schistosome eggs protects mice from TNBS-induced colitis. Am J Physiol Gastrointest Liver Physiol 2003 284 : G385 91.
17. Elliott DE, Setiawan T, Metwali A, Blum A, Urban JF Jr., Weinstock JV. Heligmosomoides polygyrus inhibits established colitis in IL-10-deficient mice. Eur J Immunol 2004 34 : 2690 8.
18. Khan WI, Blennerhasset PA, Varghese AK, Chowdhury SK, Omsted P, Deng Y, Collins SM. Intestinal nematode infection ameliorates experimental colitis in mice. Infect Immun 2002 70 : 5931 7.
19. Summers RW, Elliott DE, Urban JF Jr., Thompson R, Weinstock JV. Trichuris suis therapy in Crohn's disease. Gut 2005 54 : 87 90. (Pubitemid 40007223)
20. Summers RW, Elliott DE, Urban JF Jr., Thompson RA, Weinstock JV. Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial. Gastroenterology 2005 128 : 825 32.
21. Imai S, Tezuka H, Fujita K. A factor of inducing IgE from a filarial parasite prevents insulin-dependent diabetes mellitus in nonobese diabetic mice. Biochem Biophys Res Commun 2001 286 : 1051 8.
22. McInnes IB, Leung BP, Harnett M, Gracie JA, Liew FY, Harnett W. A novel therapeutic approach targeting articular inflammation using the filarial nematode-derived phosphorylcholine-containing glycoprotein ES-62. J Immunol 2003 171 : 2127 33.
23. Zaccone P, Burton OT, Cooke A. Interplay of parasite-driven immune responses and autoimmunity. Trends Parasitol 2008 24 : 35 42.
24. Zaccone P, Fehervari Z, Jones FM, Sidobre S, Kronenberg M, Dunne DW, Cooke A. Schistosoma mansoni antigens modulate the activity of the innate immune response and prevent onset of type 1 diabetes. Eur J Immunol 2003 33 : 1439 49.
25. Nagayama Y, Watanabe K, Niwa M, McLachlan SM, Rapoport B. Schistosoma mansoni and alpha-galactosylceramide: prophylactic effect of Th1 immune suppression in a mouse model of Graves' hyperthyroidism. J Immunol 2004 173 : 2167 73.
26. Sewell D, Qing Z, Reinke E, Elliot D, Weinstock J, Sandor M, Fabry Z. Immunomodulation of experimental autoimmune encephalomyelitis by helminth ova immunization. Int Immunol 2003 15 : 59 69. (Pubitemid 36163769)
27. Finnegan A, Mikecz K, Tao P, Glant TT. Proteoglycan (aggrecan)-induced arthritis in BALB/c mice is a Th1-type disease regulated by Th2 cytokines. J Immunol 1999 163 : 5383 90.
28. Shaw MK, Lorens JB, Dhawan A et al. Local delivery of interleukin 4 by retrovirus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis. J Exp Med 1997 185 : 1711 4.
29. Tisch R, Wang B, Weaver DJ, Liu B, Bui T, Arthos J, Serreze DV. Antigen-specific mediated suppression of beta cell autoimmunity by plasmid DNA vaccination. J Immunol 2001 166 : 2122 32.
30. Gregori S, Giarratana N, Smiroldo S, Adorini L. Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development. J Immunol 2003 171 : 4040 7.
31. Mellanby RJ, Thomas D, Phillips JM, Cooke A. Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4+ CD25+ Foxp3+ regulatory T cells. Immunology 2007 121 : 15 28.
32. Tritt M, Sgouroudis E, d'Hennezel E, Albanese A, Piccirillo CA. Functional waning of naturally occurring CD4+ regulatory T-cells contributes to the onset of autoimmune diabetes. Diabetes 2008 57 : 113 23.
33. Gregg RK, Jain R, Schoenleber SJ, Divekar R, Bell JJ, Lee HH, Yu P, Zaghouani H. A sudden decline in active membrane-bound TGF-beta impairs both T regulatory cell function and protection against autoimmune diabetes. J Immunol 2004 173 : 7308 16.
34. Tarbell KV, Petit L, Zuo X et al. Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice. J Exp Med 2007 204 : 191 201.